Statistical thinking for non-statisticians in drug regulation

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Kay, R. (VerfasserIn)
Format: Elektronisch E-Book
Sprache:English
Veröffentlicht: Chichester, West Sussex, UK Wiley Blackwell 2015
Ausgabe:Second edition
Schlagworte:
Online-Zugang:DE-861
DE-473
URL des Erstveröffentlichers
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

MARC

LEADER 00000nam a2200000zc 4500
001 BV043396821
003 DE-604
005 00000000000000.0
007 cr|uuu---uuuuu
008 160222s2015 xx o|||| 00||| eng d
020 |a 9781118470978  |c ePub  |9 978-1-118-47097-8 
020 |a 1118470974  |c ePub  |9 1-118-47097-4 
020 |a 9781118470992  |c Adobe PDF  |9 978-1-118-47099-2 
020 |a 1118470990  |c Adobe PDF  |9 1-118-47099-0 
020 |a 9781118470961  |9 978-1-118-47096-1 
020 |a 1118470966  |9 1-118-47096-6 
024 7 |a 10.1002/9781118470961  |2 doi 
035 |a (ZDB-35-WIC)ocn880831304 
035 |a (OCoLC)880831304 
035 |a (DE-599)BVBBV043396821 
040 |a DE-604  |b ger  |e aacr 
041 0 |a eng 
049 |a DE-861 
082 0 |a 615.5/80724  |2 23 
100 1 |a Kay, R.  |e Verfasser  |4 aut 
245 1 0 |a Statistical thinking for non-statisticians in drug regulation  |c Richard Kay, PhD, Statistical Consultant, RK Statistics Ltd, Honorary Visiting Professor, School of Pharmacy, Cardiff University, UK. 
250 |a Second edition 
264 1 |a Chichester, West Sussex, UK  |b Wiley Blackwell  |c 2015 
300 |a 1 Online-Ressource 
336 |b txt  |2 rdacontent 
337 |b c  |2 rdamedia 
338 |b cr  |2 rdacarrier 
500 |a Includes bibliographical references and index 
500 |a Statistical Thinking for Non-Statisticians in Drug Regulation, Second Edition, is a need-to-know guide to understanding statistical methodology, statistical data and results within drug development and clinical trials.It provides non-statisticians working in the pharmaceutical and medical device industries with an accessible introduction to the knowledge they need when working with statistical information and communicating with statisticians. It covers the statistical aspects of design, conduct, analysis and presentation of data from clinical trials in drug regulation and improves the ability to read, understand and critically appraise statistical methodology in papers and reports. As such, it is directly concerned with the day-to-day practice and the regulatory requirements of drug development and clinical trials.Fully conversant with current regulatory requirements, this second edition includes five new chapters covering Bayesian statistics, adaptive designs, observational studies, methods for safety analysis and monitoring and statistics for diagnosis.Authored by a respected lecturer and consultant to the pharmaceutical industry, Statistical Thinking for Non-Statisticians in Drug Regulation is an ideal guide for physicians, clinical research scientists, managers and associates, data managers, medical writers, regulatory personnel and for all non-statisticians working and learning within the pharmaceutical industry 
650 4 |a Clinical Trials as Topic / methods 
650 4 |a Drug Approval 
650 4 |a Drug Industry 
650 4 |a Statistics as Topic 
650 7 |a MEDICAL / Pharmacology  |2 bisacsh 
650 4 |a Medical 
650 4 |a Medizin 
650 4 |a Clinical trials / Statistical methods 
650 4 |a Drugs / Testing / Statistical methods 
650 4 |a Drug approval / Statistical methods 
650 4 |a Pharmaceutical industry / Statistical methods 
653 |a Electronic books 
776 0 8 |i Erscheint auch als  |n Druck-Ausgabe, Hardcover  |z 978-1-118-47094-7 
856 4 0 |u https://onlinelibrary.wiley.com/doi/book/10.1002/9781118470961  |x Verlag  |z URL des Erstveröffentlichers  |3 Volltext 
912 |a ZDB-35-WIC 
940 1 |q UBG_PDA_WIC 
943 1 |a oai:aleph.bib-bvb.de:BVB01-028815405 
966 e |u https://onlinelibrary.wiley.com/doi/book/10.1002/9781118470961  |l DE-861  |p ZDB-35-WIC  |q FRO_PDA_WIC  |x Verlag  |3 Volltext 
966 e |u https://onlinelibrary.wiley.com/doi/book/10.1002/9781118470961  |l DE-473  |p ZDB-35-WIC  |q UBG_PDA_WIC  |x Verlag  |3 Volltext 

Datensatz im Suchindex

_version_ 1819296157001580545
any_adam_object
author Kay, R.
author_facet Kay, R.
author_role aut
author_sort Kay, R.
author_variant r k rk
building Verbundindex
bvnumber BV043396821
collection ZDB-35-WIC
ctrlnum (ZDB-35-WIC)ocn880831304
(OCoLC)880831304
(DE-599)BVBBV043396821
dewey-full 615.5/80724
dewey-hundreds 600 - Technology (Applied sciences)
dewey-ones 615 - Pharmacology and therapeutics
dewey-raw 615.5/80724
dewey-search 615.5/80724
dewey-sort 3615.5 580724
dewey-tens 610 - Medicine and health
discipline Medizin
edition Second edition
format Electronic
eBook
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03820nam a2200601zc 4500</leader><controlfield tag="001">BV043396821</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">160222s2015 xx o|||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781118470978</subfield><subfield code="c">ePub</subfield><subfield code="9">978-1-118-47097-8</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1118470974</subfield><subfield code="c">ePub</subfield><subfield code="9">1-118-47097-4</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781118470992</subfield><subfield code="c">Adobe PDF</subfield><subfield code="9">978-1-118-47099-2</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1118470990</subfield><subfield code="c">Adobe PDF</subfield><subfield code="9">1-118-47099-0</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781118470961</subfield><subfield code="9">978-1-118-47096-1</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1118470966</subfield><subfield code="9">1-118-47096-6</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1002/9781118470961</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-35-WIC)ocn880831304</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)880831304</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043396821</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-861</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.5/80724</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Kay, R.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Statistical thinking for non-statisticians in drug regulation</subfield><subfield code="c">Richard Kay, PhD, Statistical Consultant, RK Statistics Ltd, Honorary Visiting Professor, School of Pharmacy, Cardiff University, UK.</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">Second edition</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Chichester, West Sussex, UK</subfield><subfield code="b">Wiley Blackwell</subfield><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Statistical Thinking for Non-Statisticians in Drug Regulation, Second Edition, is a need-to-know guide to understanding statistical methodology, statistical data and results within drug development and clinical trials.It provides non-statisticians working in the pharmaceutical and medical device industries with an accessible introduction to the knowledge they need when working with statistical information and communicating with statisticians. It covers the statistical aspects of design, conduct, analysis and presentation of data from clinical trials in drug regulation and improves the ability to read, understand and critically appraise statistical methodology in papers and reports. As such, it is directly concerned with the day-to-day practice and the regulatory requirements of drug development and clinical trials.Fully conversant with current regulatory requirements, this second edition includes five new chapters covering Bayesian statistics, adaptive designs, observational studies, methods for safety analysis and monitoring and statistics for diagnosis.Authored by a respected lecturer and consultant to the pharmaceutical industry, Statistical Thinking for Non-Statisticians in Drug Regulation is an ideal guide for physicians, clinical research scientists, managers and associates, data managers, medical writers, regulatory personnel and for all non-statisticians working and learning within the pharmaceutical industry</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clinical Trials as Topic / methods</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Approval</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Industry</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Statistics as Topic</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Pharmacology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medical</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clinical trials / Statistical methods</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs / Testing / Statistical methods</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug approval / Statistical methods</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry / Statistical methods</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Electronic books</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Hardcover</subfield><subfield code="z">978-1-118-47094-7</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://onlinelibrary.wiley.com/doi/book/10.1002/9781118470961</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-35-WIC</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">UBG_PDA_WIC</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028815405</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://onlinelibrary.wiley.com/doi/book/10.1002/9781118470961</subfield><subfield code="l">DE-861</subfield><subfield code="p">ZDB-35-WIC</subfield><subfield code="q">FRO_PDA_WIC</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://onlinelibrary.wiley.com/doi/book/10.1002/9781118470961</subfield><subfield code="l">DE-473</subfield><subfield code="p">ZDB-35-WIC</subfield><subfield code="q">UBG_PDA_WIC</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection>
id DE-604.BV043396821
illustrated Not Illustrated
indexdate 2024-12-24T04:53:38Z
institution BVB
isbn 9781118470978
1118470974
9781118470992
1118470990
9781118470961
1118470966
language English
oai_aleph_id oai:aleph.bib-bvb.de:BVB01-028815405
oclc_num 880831304
open_access_boolean
owner DE-861
owner_facet DE-861
physical 1 Online-Ressource
psigel ZDB-35-WIC
UBG_PDA_WIC
ZDB-35-WIC FRO_PDA_WIC
ZDB-35-WIC UBG_PDA_WIC
publishDate 2015
publishDateSearch 2015
publishDateSort 2015
publisher Wiley Blackwell
record_format marc
spelling Kay, R. Verfasser aut
Statistical thinking for non-statisticians in drug regulation Richard Kay, PhD, Statistical Consultant, RK Statistics Ltd, Honorary Visiting Professor, School of Pharmacy, Cardiff University, UK.
Second edition
Chichester, West Sussex, UK Wiley Blackwell 2015
1 Online-Ressource
txt rdacontent
c rdamedia
cr rdacarrier
Includes bibliographical references and index
Statistical Thinking for Non-Statisticians in Drug Regulation, Second Edition, is a need-to-know guide to understanding statistical methodology, statistical data and results within drug development and clinical trials.It provides non-statisticians working in the pharmaceutical and medical device industries with an accessible introduction to the knowledge they need when working with statistical information and communicating with statisticians. It covers the statistical aspects of design, conduct, analysis and presentation of data from clinical trials in drug regulation and improves the ability to read, understand and critically appraise statistical methodology in papers and reports. As such, it is directly concerned with the day-to-day practice and the regulatory requirements of drug development and clinical trials.Fully conversant with current regulatory requirements, this second edition includes five new chapters covering Bayesian statistics, adaptive designs, observational studies, methods for safety analysis and monitoring and statistics for diagnosis.Authored by a respected lecturer and consultant to the pharmaceutical industry, Statistical Thinking for Non-Statisticians in Drug Regulation is an ideal guide for physicians, clinical research scientists, managers and associates, data managers, medical writers, regulatory personnel and for all non-statisticians working and learning within the pharmaceutical industry
Clinical Trials as Topic / methods
Drug Approval
Drug Industry
Statistics as Topic
MEDICAL / Pharmacology bisacsh
Medical
Medizin
Clinical trials / Statistical methods
Drugs / Testing / Statistical methods
Drug approval / Statistical methods
Pharmaceutical industry / Statistical methods
Electronic books
Erscheint auch als Druck-Ausgabe, Hardcover 978-1-118-47094-7
https://onlinelibrary.wiley.com/doi/book/10.1002/9781118470961 Verlag URL des Erstveröffentlichers Volltext
spellingShingle Kay, R.
Statistical thinking for non-statisticians in drug regulation
Clinical Trials as Topic / methods
Drug Approval
Drug Industry
Statistics as Topic
MEDICAL / Pharmacology bisacsh
Medical
Medizin
Clinical trials / Statistical methods
Drugs / Testing / Statistical methods
Drug approval / Statistical methods
Pharmaceutical industry / Statistical methods
title Statistical thinking for non-statisticians in drug regulation
title_auth Statistical thinking for non-statisticians in drug regulation
title_exact_search Statistical thinking for non-statisticians in drug regulation
title_full Statistical thinking for non-statisticians in drug regulation Richard Kay, PhD, Statistical Consultant, RK Statistics Ltd, Honorary Visiting Professor, School of Pharmacy, Cardiff University, UK.
title_fullStr Statistical thinking for non-statisticians in drug regulation Richard Kay, PhD, Statistical Consultant, RK Statistics Ltd, Honorary Visiting Professor, School of Pharmacy, Cardiff University, UK.
title_full_unstemmed Statistical thinking for non-statisticians in drug regulation Richard Kay, PhD, Statistical Consultant, RK Statistics Ltd, Honorary Visiting Professor, School of Pharmacy, Cardiff University, UK.
title_short Statistical thinking for non-statisticians in drug regulation
title_sort statistical thinking for non statisticians in drug regulation
topic Clinical Trials as Topic / methods
Drug Approval
Drug Industry
Statistics as Topic
MEDICAL / Pharmacology bisacsh
Medical
Medizin
Clinical trials / Statistical methods
Drugs / Testing / Statistical methods
Drug approval / Statistical methods
Pharmaceutical industry / Statistical methods
topic_facet Clinical Trials as Topic / methods
Drug Approval
Drug Industry
Statistics as Topic
MEDICAL / Pharmacology
Medical
Medizin
Clinical trials / Statistical methods
Drugs / Testing / Statistical methods
Drug approval / Statistical methods
Pharmaceutical industry / Statistical methods
url https://onlinelibrary.wiley.com/doi/book/10.1002/9781118470961
work_keys_str_mv AT kayr statisticalthinkingfornonstatisticiansindrugregulation